Kuhn & Co Investment Counsel’s Eli Lilly LLY Stock Holding History

Kuhn & Co Investment Counsel’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.88M	Buy	3,238 +17	+0.5%	+$17.4K	2.24%	9
2026 Q1	$2.96M	Buy	3,221 +20	+0.6%	+$20.3K	1.91%	11
2025 Q4	$3.44M	Sell	3,201 -99	-3%	-$94.7K	2.29%	9
2025 Q3	$2.52M	Sell	3,300 -45	-1%	-$33.5K	1.99%	11
2025 Q2	$2.61M	Hold	3,345	–	–	1.97%	10
2025 Q1	$2.76M	Sell	3,345 -231	-6%	-$192K	2.33%	8
2024 Q4	$2.76M	Sell	3,576 -95	-3%	-$78.7K	2.35%	9
2024 Q3	$3.25M	Sell	3,671 -31	-0.8%	-$27.9K	2.77%	6
2024 Q2	$3.35M	Hold	3,702	–	–	3.01%	6
2024 Q1	$2.88M	Sell	3,702 -359	-9%	-$255K	2.71%	7
2023 Q4	$2.37M	Buy	+4,061	New	+$2.37M	2.43%	6

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kuhn & Co Investment Counsel's LLY Position: Q2 2026 in Review

Kuhn & Co Investment Counsel increased its Eli Lilly (LLY) stake by 0.53% in Q2 2026, buying an estimated $17.4K and bringing the position to 3,238 shares worth $3.88M. The position accounts for 2.24% of the portfolio, ranked #9.

Kuhn & Co Investment Counsel first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Kuhn & Co Investment Counsel held 3,238 shares of Eli Lilly worth $3.88M as of Q2 2026.
Kuhn & Co Investment Counsel bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
Eli Lilly made up 2.24% of Kuhn & Co Investment Counsel's portfolio in Q2 2026, its #9 holding.
Kuhn & Co Investment Counsel first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.